BIOMAT Database Logo BIOMAT Database Logo

[Primary malignant tumors of the ovary. Clinical evaluation of the therapeutic effect of 2,3,5-tris-ethyleneimino-1,4-benzoquinone]. 1966

P Hernández Padilla, and R Roldán

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014228 Triaziquone Alkylating antineoplastic agent used mainly for ovarian tumors. It is toxic to skin, gastrointestinal tract, bone marrow and kidneys. 2,3,5-Tris(ethyleneimine)benzoquinone,Trenimon

Related Publications

P Hernández Padilla, and R Roldán
[Effect of 2,3,5-tris-ethylenimino-benzoquinone-(1,4) on inoculation tumors].
July 1963, Arzneimittel-Forschung,
P Hernández Padilla, and R Roldán
[ON THE EFFECT OF 2,3,5-TRIS(ETHYLENEIMINO)-P-BENZOQUINONE (TRENIMON) ON THE METABOLISM OF JENSEN SARCOMA].
February 1965, Zeitschrift fur Krebsforschung,
P Hernández Padilla, and R Roldán
[Clinical experience on the antineoplastic activity of tris-ethyleneimino-benzoquinone].
January 1963, Tumori,
P Hernández Padilla, and R Roldán
2,3,5-Tris-ethylenimino-1,4-benzoquinone (Trenimon): some chemical and biological properties.
March 1973, Chemico-biological interactions,
P Hernández Padilla, and R Roldán
[Clinical experience on the anti-neoplastic activity of tris-ethyleneimino-benzoquinone].
January 1963, Tumori,
P Hernández Padilla, and R Roldán
[The influence of Trenimon (2,3,5-tris-ethyleneimino-benzoquinone-1,4) on the content of free nicotinic acid and free nicotinamide in Ehrlich ascites tumor cells].
January 1967, Zeitschrift fur Krebsforschung,
P Hernández Padilla, and R Roldán
Interaction of the alkylating antitumor agent 2,3,5-tris(ethyleneimino)benzoquinone with the plasma membrane of Ehrlich ascites tumor cells.
January 1981, Cancer research,
P Hernández Padilla, and R Roldán
[On the mode of action of the cytostatic agent 2,3,5-tris-ethyleneimino-benzoquinome-(1,4) on nucleic acid metabolism. Autoradiographic studies].
February 1968, Arzneimittel-Forschung,
P Hernández Padilla, and R Roldán
[THE EFFECTS OF 2,3,5-TRIS-ETHYLENIMINO-1,4-BENZOQUINONE ON OXYGEN-CONSUMING REACTIONS IN YOSHIDA ASCITES SARCOMA CELLS].
July 1964, Arzneimittel-Forschung,
P Hernández Padilla, and R Roldán
[Therapy of hemoblastoses and malignant tumors with 2,3,5-tris-ethyleneiminobenzoquinone].
October 1960, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!